BetterScholar BetterScholar
12
Role
Title
Level Year L/R
🐜 Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.
26 auth. J. Kochenderfer, M. Dudley, Sadik H. Kassim, R. Somerville, R. O. Carpenter, M. Stetler-Stevenson, J. Yang, G. Phan, M. Hughes, R. Sherry, M. Raffeld, Steven R. Feldman, Lily Lu, Yong F Li, L. Ngo, ... A. Goy, T. Feldman, D. Spaner, Michael L. Wang, Clara C. Chen, S. Kranick, A. Nath, Debbie-Ann N. Nathan, K. Morton, M. A. Toomey, S. Rosenberg
10 2015
10
🐜
🐜 Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
25 auth. L. Johnson, R. Morgan, M. Dudley, L. Cassard, J. Yang, M. Hughes, U. Kammula, R. Royal, R. Sherry, J. Wunderlich, C. Lee, N. Restifo, S. Schwarz, Alexandria P. Cogdill, R. Bishop, ... Hung Kim, C. Brewer, Susan F. Rudy, C. Vanwaes, Jeremy L. Davis, A. Mathur, R. Ripley, Debbie-Ann N. Nathan, C. Laurencot, S. Rosenberg
10 2009
10
🐜
🐜 B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.
18 auth. J. Kochenderfer, M. Dudley, S. Feldman, W. Wilson, D. Spaner, I. Maric, M. Stetler-Stevenson, G. Phan, M. Hughes, R. Sherry, ... J. Yang, U. Kammula, Laura Devillier, R. Carpenter, Debbie-Ann N. Nathan, R. Morgan, C. Laurencot, S. Rosenberg
10 2012
10
🐜
🐜 Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
12 auth. J. Kochenderfer, W. Wilson, J. Janik, M. Dudley, M. Stetler-Stevenson, S. Feldman, ... I. Maric, M. Raffeld, Debbie-Ann N. Nathan, B. Lanier, R. Morgan, S. Rosenberg
10 2010
10
🐜
🐜 T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis.
19 auth. M. Parkhurst, J. Yang, R. Langan, M. Dudley, Debbie-Ann N. Nathan, S. Feldman, Jeremy L. Davis, R. Morgan, M. Merino, R. Sherry, ... M. Hughes, U. Kammula, G. Phan, Ramona M. Lim, S. Wank, N. Restifo, P. Robbins, C. Laurencot, S. Rosenberg
9 2011
9
🐜
🐜 T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.
19 auth. M. Parkhurst, J. Yang, R. Langan, M. Dudley, Debbie-Ann N. Nathan, S. Feldman, Jeremy L. Davis, R. Morgan, M. Merino, R. Sherry, ... M. Hughes, U. Kammula, G. Phan, Ramona M. Lim, S. Wank, N. Restifo, P. Robbins, C. Laurencot, S. Rosenberg
8 2011
8
🐜
🐜 Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.
18 auth. M. Dudley, Colin Gross, R. Somerville, Y. Hong, Nicholas P. Schaub, Shannon F. Rosati, D. White, Debbie-Ann N. Nathan, N. Restifo, S. Steinberg, ... J. Wunderlich, U. Kammula, R. Sherry, J. Yang, G. Phan, M. Hughes, C. Laurencot, S. Rosenberg
7 2013
7
🐜
🐜 Effective Treatment Of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma With Autologous T Cells Genetically-Engineered To Express An Anti-CD19 Chimeric Antigen Receptor
13 auth. M. Dudley, Sadik H. Kassim, R. O. Carpenter, J. Yang, G. Phan, M. Hughes, R. Sherry, Steven R. Feldman, D. Spaner, Debbie-Ann N. Nathan, ... K. Morton, M. A. Toomey, S. Rosenberg
3 2013
3
🐜
🐜 A Phase I Clinical Trial of Treatment of B-Cell Malignancies with Autologous Anti-CD19-CAR-Transduced T Cells
11 auth. J. Kochenderfer, M. Dudley, M. Stetler-Stevenson, W. Wilson, J. Janik, Debbie-Ann N. Nathan, ... I. Maric, M. Raffeld, S. Feldman, R. Morgan, S. Rosenberg
3 2010
3
🐜
🦁 regression and targets normal tissues expressing cognate antigen Gene therapy with human and mouse T-cell receptors mediates cancer
23 auth. Debbie-Ann N. Nathan, C. Laurencot, S. Rosenberg, C. Brewer, Susan F. Rudy, C. Vanwaes, Jeremy L. Davis, A. Mathur, N. Restifo, S. Schwarz, ... Alexandria P. Cogdill, R. Bishop, Hung Kim, U. Kammula, R. Royal, R. Sherry, J. Wunderlich, L. Johnson, R. Morgan, M. Dudley, L. Cassard, J. Yang, S. Marybeth
2 2009
2
🦁
🐜 B-Cell Depletion, Remissions of Malignancy, and Cytokine-Associated Toxicity in a Clinical Trial of T Cells Genetically-Engineered to Express An Anti-CD19 Chimeric Antigen Receptor
11 auth. J. Kochenderfer, M. Dudley, Steven R. Feldman, W. Wilson, D. Spaner, Laura Devillier, ... R. Carpenter, Debbie-Ann N. Nathan, I. Maric, R. Morgan, S. Rosenberg
1 2011
1
🐜